Evidence map›Paper›PMID 26648527›Full record

ArticleScientific reports2015

Predicting cancerlectins by the optimal g-gap dipeptides.

Hao Lin, Wei-Xin Liu, Jiao He, Xin-Hui Liu, Hui Ding, Wei Chen

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. iRSpot-Pse6NC: Identifying recombination spots inInternational journal of biological sciences · 2018
    Article
  14. HBPred: a tool to identify growth hormone-binding proteins.International journal of biological sciences · 2018
    Article
  15. Article
  16. Article
  17. IonchanPred 2.0: A Tool to Predict Ion Channels and Their Types.International journal of molecular sciences · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hao LinKey Laboratory for Neuro-Information of Ministry of Education, Center of Bioinformatics, School of Life Science and Technology, Center for Information in Biomedicine, University of Electronic Science and Technology of China, Chengdu 610054, China.
Wei-Xin LiuKey Laboratory for Neuro-Information of Ministry of Education, Center of Bioinformatics, School of Life Science and Technology, Center for Information in Biomedicine, University of Electronic Science and Technology of China, Chengdu 610054, China.
Jiao HeKey Laboratory for Neuro-Information of Ministry of Education, Center of Bioinformatics, School of Life Science and Technology, Center for Information in Biomedicine, University of Electronic Science and Technology of China, Chengdu 610054, China.
Xin-Hui LiuSchool of Linguistics and Literature, University of Electronic Science and Technology of China, Chengdu 610054, China.
Hui DingKey Laboratory for Neuro-Information of Ministry of Education, Center of Bioinformatics, School of Life Science and Technology, Center for Information in Biomedicine, University of Electronic Science and Technology of China, Chengdu 610054, China.
Wei ChenKey Laboratory for Neuro-Information of Ministry of Education, Center of Bioinformatics, School of Life Science and Technology, Center for Information in Biomedicine, University of Electronic Science and Technology of China, Chengdu 610054, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cancerlectin plays a key role in the process of tumor cell differentiation. Thus, to fully understand the function of cancerlectin is significant because it sheds light on the future direction for the cancer therapy. However, the traditional wet-experimental methods were money- and time-consuming. It is highly desirable to develop an effective and efficient computational tool to identify cancerlectins. In this study, we developed a sequence-based method to discriminate between cancerlectins and non-cancerlectins. The analysis of variance (ANOVA) was used to choose the optimal feature set derived from the g-gap dipeptide composition. The jackknife cross-validated results showed that the proposed method achieved the accuracy of 75.19%, which is superior to other published methods. For the convenience of other researchers, an online web-server CaLecPred was established and can be freely accessed from the website http://lin.uestc.edu.cn/server/CalecPred. We believe that the CaLecPred is a powerful tool to study cancerlectins and to guide the related experimental validations.

Indexed as

Computational BiologyDatabases, ProteinDipeptidesHumansLectinsNeoplasmsReproducibility of ResultsSoftwareWeb BrowserDipeptidesLectins

Identifiers

PMID26648527
PMCPMC4673586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.